These results parallel those in the present study, in which, after adjusting for confounders, blood pressure and glucose but not metabolic syndrome were useful in predicting those that will have progression of subclinical atherosclerosis.
Some limitations of the study due to its cross-sectional nature are that we were unable to identify if controls without rheumatic disorders who depicted positivity to one or both autoantibodies will have progression to a CIRD in the future; nevertheless, this hypothesis should be tested in cohort models, increasing the number of patients.
Despite many therapeutic efforts using new chemotherapies, approximately 80% of patients with advanced OC will have tumor progression or recurrence.
Although the relationship has been established [ 33- 36], currently it is still difficult to predict who among the patients with early or very early RA will have radiographic progression of their disease.
> -wrap-foot> aHUS is a challenging disease to manage with a relatively poor prognosis, as up to 65% of patients treated with PE will sustain permanent renal damage, have progression to end-stage renal disease (ESRD) or die within 1 year [ 6].
"A good game will have the expected progression at the end of each level, but it will also provide surprise rewards halfway through," says Ben Weedon, a consultant at PlayableGames, a company that carries out usability testing on new titles before they're released.
The impact this increase in novel recombinants will have on disease progression, treatment and the development of drug resistance is not yet known.
The first-line treatment of patients with KIT-positive, unresectable, recurrent, and/or metastatic gastrointestinal stromal tumor (GIST) is the oral tyrosine kinase inhibitor (TKI) imatinib; however, half of the patients will have experienced disease progression after ∼20 months [ 1].
It is clear that the linking of two pathways so critical to tumour development and progression will have a significant impact on cancer therapy.
A better understanding of BPS, including their definition, evaluation, underlying mechanisms, risk factors, prevalence and progression will have important implications for prevention and treatment.
Furthermore, measures to prevent such progression will have a major impact in the quality of life of Europeans and public health outcomes.
